Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) FCF Margin (2016 - 2025)

Tandem Diabetes Care's FCF Margin history spans 13 years, with the latest figure at 2.38% for Q4 2025.

  • For Q4 2025, FCF Margin fell 32.0% year-over-year to 2.38%; the TTM value through Dec 2025 reached 1.32%, down 185.0%, while the annual FY2025 figure was 1.32%, 185.0% down from the prior year.
  • FCF Margin reached 2.38% in Q4 2025 per TNDM's latest filing, down from 6.66% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 19.68% in Q1 2021 to a low of 13.22% in Q1 2023.
  • Average FCF Margin over 5 years is 2.43%, with a median of 2.54% recorded in 2024.
  • Peak YoY movement for FCF Margin: surged 4267bps in 2021, then plummeted -2021bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 9.31% in 2021, then tumbled by -217bps to 10.87% in 2022, then skyrocketed by 154bps to 5.81% in 2023, then plummeted by -53bps to 2.71% in 2024, then dropped by -12bps to 2.38% in 2025.
  • Per Business Quant, the three most recent readings for TNDM's FCF Margin are 2.38% (Q4 2025), 6.66% (Q3 2025), and 6.52% (Q2 2025).